An increase in urinary primaquine and a reduction in urinary primaquine-5, 6-orthoquinone in the Thai population with CYP2D6 reduced enzyme function
W Pookmanee, S Thongthip, M Mungthin, C Sukasem… - Heliyon, 2024 - cell.com
Objectives Primaquine is metabolized by the cytochrome P450-2D6 enzyme (CYP2D6) to
an active primaquine-5, 6-orthoquinone (POQ). No relationships of CYP2D6 polymorphisms …
an active primaquine-5, 6-orthoquinone (POQ). No relationships of CYP2D6 polymorphisms …
Identification of key pathways and genes in dementia via integrated bioinformatics analysis
B Vastrad, C Vastrad - bioRxiv, 2021 - biorxiv.org
To provide a better understanding of dementia at the molecular level, this study aimed to
identify the genes and key pathways associated with dementia by using integrated …
identify the genes and key pathways associated with dementia by using integrated …
Transient depersonalisation/derealisation syndrome from tramadol
S Thumtecho, S Wainipitapong… - BMJ Case Reports …, 2023 - casereports.bmj.com
Depersonalisation/derealisation (DD) syndrome is often associated with severe traumatic
experiences and the use of certain medications. Our patient reported experiencing a …
experiences and the use of certain medications. Our patient reported experiencing a …
A pharmacovigilance study of gender differences in rhabdomyolysis risk among donepezil users with alzheimers disease
Z Ahmed - 2023 - dspace.bracu.ac.bd
Alzheimer's disease is the most common disease for older patients marked by symptoms of
dementia. This study was conducted for the pharmacovigilance investigation of donepezil …
dementia. This study was conducted for the pharmacovigilance investigation of donepezil …